Pretest PSA and Restaging PSMA PET/CT Predict Survival in Biochemically Recurrent Prostate Cancer

Background: A biochemical recurrence (BCR) risk model was created based on pretest prostate specific antigen (PSA) and groupings by restaging prostate specific membrane antigen (PSMA) PET/CT. Methods: A cohort of 1216 BCR patients were analyzed for overall survival (OS) according to the PSA threshol...

Descripción completa

Detalles Bibliográficos
Autores principales: von Eyben, Rie, Hoffmann, Manuela Andrea, Soydal, Cigdem, Virgolini, Irene, Tuncel, Murat, Gauthé, Mathieu, Kapp, Daniel S., von Eyben, Finn Edler
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10525266/
https://www.ncbi.nlm.nih.gov/pubmed/37760775
http://dx.doi.org/10.3390/biomedicines11092333

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10525266/
https://www.ncbi.nlm.nih.gov/pubmed/37760775
http://dx.doi.org/10.3390/biomedicines11092333

Ejemplares similares